SCHOLAR ROCK HOLDING CORPORATION Other Current Liabilities
SCHOLAR ROCK HOLDING CORPORATION (SRRK) had Other Current Liabilities of $107.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2025-02-27
- 2024-03-31: Other Liabilities, Current $107.00K.
- 2023-12-31: Other Liabilities, Current $85.00K.
- 2023-09-30: Other Liabilities, Current $165.00K.
- 2023-06-30: Other Liabilities, Current $141.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2024-03-31 | $107.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $85.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $165.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $141.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $121.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $222.00K 10-K · filed 2024-03-19 |
| 2022-03-31 | $244.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $230.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $228.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $236.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $235.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $15.00K 10-K · filed 2022-03-07 |
| 2020-09-30 | $17.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $20.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $19.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $16.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | $15.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $15.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $15.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $14.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |